The Native GlobalVision Alternative for Pharma Packaging Proofing & Inspection
Novaqis AMS is the leading cost-effective alternative to standalone graphic inspection utilities like GlobalVision Desktop & Cloud, engineered specifically for regulated life sciences, virtual pharma marketers, and prepress quality teams. By replacing restrictive per-workstation software licenses ($15,000–$35,000/seat) with browser-based site licensing, Novaqis delivers pixel and 1200 DPI vector diffing, character-level text verification, and ISO 15415/15416 barcode grading natively inside an integrated 21 CFR Part 11 artwork lifecycle and regulatory dossier platform.
Novaqis AMS vs. GlobalVision
Standalone Inspection Utility vs. Novaqis AMS Native Proofing Suite
Compare architectural, commercial, and operational vectors across regulatory intelligence, complete workflow routing, inspection depth, workstation licensing economics, and QMS change control locking.
| Dimension | GlobalVision (Standalone Inspection Utility) | Novaqis AMS Integrated Proofing Suite |
|---|---|---|
Regulatory Intelligence & Dossier Linkage Connected SmPC lifecycle vs. isolated file-vs-file desktop tool | GlobalVision is strictly an inspection utility comparing two uploaded files; it lacks knowledge of country Marketing Authorizations, CTD/ACTD dossier variations, or renewal deadlines. | Unified Regulatory Information Management (RIM) linking health authority submissions and approved SmPC texts directly to active packaging dielines, cartons, and blister foils across all export territories. |
Full Lifecycle Artwork Workflow & Review Routing End-to-end routing and approval governance vs inspection-only | Pure graphic and text diffing utility; requires purchasing and configuring a secondary workflow management tool (ManageArtworks, Veeva, or Esko WebCenter) to route files for approval. | Complete end-to-end Artwork Management System (AMS): automated stage-gate routing, role-based review steps (RA, QA, Packaging, Legal, Medical), and 21 CFR Part 11 cryptographic e-signatures built into the diff viewer. |
Inspection Depth: Vector, Text, Braille & Barcodes Character extraction, layer isolation, and barcode grading | Requires expensive modular add-ons (Text Inspection, Barcode Inspection, Braille Inspection, Graphic Inspection licensed separately per feature). | All-in-one native inspection suite: 1200 DPI vector diffing, character-level font/text verification, Braille dot spacing & height validation, and ISO 15415/15416 DataMatrix & Pharmacode grading included at $0 extra charge. |
Licensing Economics: Per-Workstation vs Site License Heavy desktop workstation seat tax vs zero seat penalties | Punitive per-workstation or per-named-user licensing ($15,000–$35,000+ per seat plus annual maintenance), forcing teams to funnel all proofing through one or two dedicated QA inspection workstations. | 100% browser-based with zero workstation or user seat limits. Regulatory, QA, packaging engineers, external CDMOs, and printing converters proof simultaneously without license rationing. |
QMS Change Control & Deviation Cryptographic Gates Controlled release governance vs unmanaged file diff reports | Inspection reports are saved as disconnected PDF files that must be manually attached to separate QMS deviation or change control forms, leaving dangerous audit trail gaps. | Cryptographically bound to Novaqis QMS: diff reports, coordinate-pinned annotations, and reviewer sign-offs automatically bind to Change Control CC-XXXX and batch records with immutable ALCOA+ audit trails. |
Deployment & Validation Stance (GAMP 5 CSA) Turnkey qualification vs local client validation overhead | Requires qualifying local client software installations and frequent software patch cycles on individual corporate workstations across operating systems. | Zero-install browser application deployable on-premises or private VPC with pre-scripted automated GAMP 5 Category 4 IQ/OQ execution packs aligned with FDA CSA principles. |
Regulatory Intelligence & Dossier Linkage
Connected SmPC lifecycle vs. isolated file-vs-file desktop tool
Unified Regulatory Information Management (RIM) linking health authority submissions and approved SmPC texts directly to active packaging dielines, cartons, and blister foils across all export territories.
GlobalVision is strictly an inspection utility comparing two uploaded files; it lacks knowledge of country Marketing Authorizations, CTD/ACTD dossier variations, or renewal deadlines.
Full Lifecycle Artwork Workflow & Review Routing
End-to-end routing and approval governance vs inspection-only
Complete end-to-end Artwork Management System (AMS): automated stage-gate routing, role-based review steps (RA, QA, Packaging, Legal, Medical), and 21 CFR Part 11 cryptographic e-signatures built into the diff viewer.
Pure graphic and text diffing utility; requires purchasing and configuring a secondary workflow management tool (ManageArtworks, Veeva, or Esko WebCenter) to route files for approval.
Inspection Depth: Vector, Text, Braille & Barcodes
Character extraction, layer isolation, and barcode grading
All-in-one native inspection suite: 1200 DPI vector diffing, character-level font/text verification, Braille dot spacing & height validation, and ISO 15415/15416 DataMatrix & Pharmacode grading included at $0 extra charge.
Requires expensive modular add-ons (Text Inspection, Barcode Inspection, Braille Inspection, Graphic Inspection licensed separately per feature).
Licensing Economics: Per-Workstation vs Site License
Heavy desktop workstation seat tax vs zero seat penalties
100% browser-based with zero workstation or user seat limits. Regulatory, QA, packaging engineers, external CDMOs, and printing converters proof simultaneously without license rationing.
Punitive per-workstation or per-named-user licensing ($15,000–$35,000+ per seat plus annual maintenance), forcing teams to funnel all proofing through one or two dedicated QA inspection workstations.
QMS Change Control & Deviation Cryptographic Gates
Controlled release governance vs unmanaged file diff reports
Cryptographically bound to Novaqis QMS: diff reports, coordinate-pinned annotations, and reviewer sign-offs automatically bind to Change Control CC-XXXX and batch records with immutable ALCOA+ audit trails.
Inspection reports are saved as disconnected PDF files that must be manually attached to separate QMS deviation or change control forms, leaving dangerous audit trail gaps.
Deployment & Validation Stance (GAMP 5 CSA)
Turnkey qualification vs local client validation overhead
Zero-install browser application deployable on-premises or private VPC with pre-scripted automated GAMP 5 Category 4 IQ/OQ execution packs aligned with FDA CSA principles.
Requires qualifying local client software installations and frequent software patch cycles on individual corporate workstations across operating systems.
5-Year Mid-Market TCO: Stop Paying per-Workstation Inspection Taxes
Typical investment comparison for a mid-market life sciences firm supporting 5 internal inspection workstations plus 10 external contract manufacturing (CDMO) and printer partners over a 5-year lifecycle.
| Cost Center / Evaluation Scope | GlobalVision Workstations + Sprawl | Novaqis Unified AMS Suite |
|---|---|---|
| Workstation Software Licenses (5-Year) | $175,000+ 5 GlobalVision desktop client licenses ($35k/seat initial + maint.) | $95,000 Flat enterprise site license ($0 per-workstation seat tax) |
| Modular Inspection Add-Ons (Barcode, Braille, Text) | $65,000+ Separate fees for Barcode Inspection, Braille, and Text diff modules | $0 All inspection capabilities included natively in core platform |
| Separate Artwork Workflow System (AMS / eDMS) | $120,000+ Required workflow tool (Esko, ManageArtworks, or custom) | $0 End-to-end stage-gate workflow & 21 CFR Part 11 e-signatures included |
| External Vendor Access & Collaborator Logins | $45,000+ License rationing prevents giving outside printers direct access | $0 Unlimited zero-fee external CDMO and printer guest portals |
| Local Workstation Validation & IT Maintenance | $35,000+ Validating individual PC desktop installations and patch updates | $20,000 Turnkey browser-based GAMP 5 Category 4 automated OQ pack |
| Estimated 5-Year Total Investment | $440,000+ Disconnected inspection workstations with high recurring seat taxes | $115,000 Predictable, unified platform investment (~74% 5-year savings) |
Workstation Software Licenses (5-Year)
Flat enterprise site license ($0 per-workstation seat tax)
5 GlobalVision desktop client licenses ($35k/seat initial + maint.)
Modular Inspection Add-Ons (Barcode, Braille, Text)
All inspection capabilities included natively in core platform
Separate fees for Barcode Inspection, Braille, and Text diff modules
Separate Artwork Workflow System (AMS / eDMS)
End-to-end stage-gate workflow & 21 CFR Part 11 e-signatures included
Required workflow tool (Esko, ManageArtworks, or custom)
External Vendor Access & Collaborator Logins
Unlimited zero-fee external CDMO and printer guest portals
License rationing prevents giving outside printers direct access
Local Workstation Validation & IT Maintenance
Turnkey browser-based GAMP 5 Category 4 automated OQ pack
Validating individual PC desktop installations and patch updates
Estimated 5-Year Total Investment
Bottom LinePredictable, unified platform investment (~74% 5-year savings)
Disconnected inspection workstations with high recurring seat taxes
Projected 5-Year Capital Preservation: ~$325,000 Saved (~74% Savings)
Enable unlimited QA and packaging reviewers on the web without paying per-seat desktop workstation penalties.
Experience the Novaqis Native Prepress Inspection Engine
Test layer toggling (CAD Dielines, Braille, Varnish, Artwork), coordinate-pinned character extraction, and automated ISO 15415/15416 barcode grading right inside your browser with zero desktop software installation:
Format: High-Res Vector PDF / CAD Dieline (1200 DPI) · Carton Size: 125 × 65 × 32 mm
Amoxicillin & Potassium Clavulanate Tablets IP
625 mg (500 mg + 125 mg)
Composition: Each film-coated tablet contains Amoxicillin Trihydrate IP eq. to Amoxicillin 500mg, Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg.
Prepress Layer Visibility6 of 6 Active
Toggle specialized packaging layers without installing Adobe Illustrator or CorelDraw desktop suites.
4-Week Validated Migration: From Standalone Inspection to Novaqis AMS
Transition prepress proofing profiles, inspection tolerances, and barcode parameters with pre-scripted GAMP 5 Category 4 automated test scripts.
Inspection Parameter Benchmarking
Mapping your current GlobalVision inspection tolerances: pixel diff thresholds, font kerning bounds, Braille spacing, and ISO barcode grading parameters.
Browser-Native Workflow Setup
Configuring role-based review stages across RA, QA, Packaging Development, and external packaging print converters.
GAMP 5 CSA Automated Qualification
Executing automated IQ/OQ inspection test packs aligned with US FDA Computer Software Assurance (CSA) principles.
Plant-Wide Cutover & Training
Decommissioning costly individual workstation licenses and onboarding unlimited internal and external reviewers via secure web portals.
Frequently Asked Questions: Replacing GlobalVision
Technical, validation, and commercial answers for QA Directors, Prepress Engineers, and RA Heads.
What is the primary difference between GlobalVision and Novaqis AMS?
GlobalVision is a point inspection engine requiring separate workflow, document management, and QMS tools to manage approvals and change controls. Novaqis AMS is a complete, unified Packaging Artwork and Document Management System that includes pixel and vector diffing, text extraction, and barcode grading natively—eliminating third-party inspection licenses and bridging regulatory dossiers directly to packaging files.
Does Novaqis AMS provide the same inspection fidelity as GlobalVision?
Yes. Novaqis AMS delivers enterprise-grade prepress inspection capabilities: high-resolution vector (.ai, .eps, .cdr, CAD, PDF) layer toggling (separating dielines, Braille, varnish, and technical drawings), character-level font and Unicode text extraction, coordinate-pinned spatial annotations, and ISO/IEC 15415/15416 grading for GS1 DataMatrix (2D), EAN/UPC (1D), QR, and Pharmacodes.
How does Novaqis eliminate GlobalVision workstation licensing costs?
GlobalVision charges steep per-workstation or per-named-user licensing ($15,000–$35,000+ per seat plus annual maintenance), forcing companies to restrict inspection access to a few QA workstations. Novaqis operates 100% in modern web browsers under an unlimited enterprise site license ($0 per-workstation fee), allowing unlimited QA, RA, packaging engineers, external CDMOs, and printers to inspect files simultaneously.
How does Novaqis AMS handle multi-language package inserts (PILs) and regional variations?
Novaqis AMS features a Unicode character-level text comparison engine that supports complex multi-script packaging, including bilingual Arabic/English (SFDA/MOHAP), Cyrillic (CIS/EAEU), and Southeast Asian scripts (ASEAN). The engine detects missing accents, font kerning shifts, and line wraps that could cause critical health authority compliance rejections.
Can print suppliers and contract packagers inspect packaging files without desktop installations?
Yes. Because Novaqis AMS is entirely browser-based, external packaging converters, repro houses, and contract packagers access files through authenticated, tokenized review portals without installing local client software or purchasing proprietary licenses.
Stop Rationing Workstation Seats for Packaging Inspection
Eliminate costly desktop workstation licenses, bring character-level proofing into your web browser, and connect every packaging change directly to regulatory dossiers and QMS change control.